The AI boom could strengthen Epic's position, health system execs say. Here's where startups and health tech vendors can still win
fiercehealthcare - Clinician-facing AI, imaging AI, patient AI assistants, discharge and care transitions and revenue cycle AI are the categories where health systems are most willing to look beyond Epic, executives said.
AI Summary: Health system executives warn that the surge in AI interest is strengthening incumbent EHR vendors, notably Epic, which can bundle AI features into existing workflows at scale. Startups face an uphill battle unless they target niche integration gaps, interoperability wins or demonstrable ROI — in short, cleverness and agility beat nostalgia for disruption.
- Connecting care: interoperability, prior auth and data exchange (5)
- Epic's AI offensive: UGM rollouts, tools and tokenomics (9)
- Health systems scaling AI: governance, ROI and safety (7)
- Startups and vendors: where to pivot in an Epic world (7)
- All Other Stories
Connecting care: interoperability, prior auth and data exchange
Epic's AI offensive: UGM rollouts, tools and tokenomics
Health systems scaling AI: governance, ROI and safety
Startups and vendors: where to pivot in an Epic world
All Other Stories
AstraZeneca Holds Preliminary Talks with Bristol Myers Squibb on Potential $400 Billion Merger
oncodaily - A deal that could create the world’s fourth-largest drugmaker British pharmaceutical leader AstraZeneca has held confidential, preliminary discussions regarding a potential combination with US rival Bristol Myers Squibb(BMS). A completed […]
AI Summary: AstraZeneca entered preliminary, non-binding talks with Bristol Myers Squibb about a potential $400 billion merger, probing whether combining pipelines and scale could reshape oncology and other businesses. The discussions are early, sparking market speculation and likely regulatory scrutiny as executives weigh strategic synergies against integration complexity and antitrust risk.
Tufts Medicine CEO, CFO step down amid financial struggles
Jill Hughes / healthcaredive - Chief Executive Mike Dandorph will remain in the position through the end of September, after which he will be replaced by COO Phil Okala. Tufts is also swapping out its chief financial officer.
AI Summary: Tufts Medicine announced the departure of its CEO and CFO amid ongoing financial struggles, prompting a leadership shake‑up as the health system pursues fiscal stabilization. Trustees and executives are now tasked with steadying operations and advancing a turnaround plan while maintaining patient services — the corporate surgery no one asked for.
New bipartisan 340B reform bill curbs HHS' rebate pilot
fiercehealthcare - The SUSTAIN 340B Act introduced Wednesday would bring hospital-backed changes, like a clearinghouse to handle improper discounts, and codifies longstanding grey areas in the contentious subsidy program.
AI Summary: Bipartisan lawmakers introduced legislation to rein in HHS’s controversial 340B rebate pilot, pushing back on administrative changes that providers say threaten safety‑net funding. The bill aims to pause or limit the pilot while stakeholders debate drug‑pricing impacts, reimbursements and patient access — the predictable Washington policy scrum.